Tafoxiparin for the treatment of preeclampsia
AssigneeDilafor AB
InventorsLena Degling-Wikingsson, Gunvor Ekman-Ordeberg, Stefan Hansson
Life of this patent
Estimating the term…
Abstract
The present invention is directed to the use of the heparin derivative tafoxiparin in the treatment of preeclampsia (PE). The treatment may be monotherapy or combination therapy, where tafoxiparin is used in combination with an agent (drug) used as standard of care therapy in preeclampsia (PE).
Claims26
The heparin derivative tafoxiparin for use in the treatment of preeclampsia (PE).
A method for the treatment of preeclampsia, whereby a therapeutically effective amount of the heparin derivative tafoxiparin is administered to a woman in need of such treatment.
Use of the heparin derivative tafoxiparin for the manufacture of a medicament for the treatment of preeclampsia (PE).
Dependencies are inferred from the claim text.